Oral vs. Topical TXA: Comparable Effectiveness and Safety in treatment of Melasma Dr. Shravani Dali12 Sept 2025 8:45 PM ISTMelasma is a chronic pigmentary disorder characterized by symmetric, hyperpigmented macules and patches on sun-exposed areas, most commonly the face....
Upadacitinib Shows Safety and Efficacy in Adolescents with Severe Alopecia Areata: Study Dr. Shravani Dali11 Sept 2025 8:15 PM ISTAlopecia areata (AA) is a chronic, immune-mediated disorder characterized by non-scarring hair loss, with profound psychological and social...
Rajasthan Increases PG Bond Penalty to Rs 1.5 Crore for Key Specialties Anshika Mishra8 Sept 2025 5:30 PM ISTAiming to meet the shortage of doctors in government hospitals, the Rajasthan Medical Education Department has announced the implementation of a new...
Health Bulletin 08/September/2025 Anshika Mishra8 Sept 2025 5:18 PM ISTHere are the top health stories of the day:GB Pant Ex-HoD gets Health Ministry notice for 3-Year Absence, Canada Film CareerThe Union Health Ministry...
Rajasthan PG Bond Penalty now upto Rs 1.5 crore- Highest for Dermatology, Radiodiagnosis, Gynaecology, Medicine Barsha Misra7 Sept 2025 11:00 AM ISTJaipur: Aiming to meet the shortage of doctors in government hospitals, the Rajasthan Medical Education Department has announced the...
Lebrikizumab Shows Strong Efficacy and Safety in Atopic Dermatitis: Study Dr. Shravani Dali20 Aug 2025 8:45 PM ISTAtopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that significantly impacts quality of life and often requires systemic...
CDSCO Panel Accepts Glenmark's Apremilast Trial Report, Seeks 2-Year PSUR Data Parthika Patel10 Aug 2025 1:00 PM ISTNew Delhi: Glenmark Pharmaceuticals Limited has received approval from the Subject Expert Committee (SEC), functioning under the Central Drugs...
Efinaconazole 10% Proven Safe and Effective for Toenail Fungus in Older Adults: Study Dr Riya Dave3 Aug 2025 8:45 PM ISTA post hoc study published in Mycoses has confirmed that efinaconazole 10% solution is both effective and safe for treating toenail onychomycosis in...
Deucravacitinib Relieves Skin and Joint Symptoms in Psoriasis and Psoriatic Arthritis: Study Dr Riya Dave31 July 2025 8:45 PM ISTResearchers have found in a new research that deucravacitinib significantly improves joint pain and musculoskeletal symptoms in patients with...
The Minds Behind IJDVL: Conversations with Dr. Archana Singal, Dr. Geeti Khullar, Dr. Pooja Arora & Dr. Sunny Duttagupta Dr. Nandita Mohan28 July 2025 7:45 AM ISTIn this video, we shine a spotlight on the recent success of Indian Journal of Dermatology, Venereology and Leprology, where its impact factor has...
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis Parthika Patel4 July 2025 3:00 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs...
Methotrexate Microinfusion Shows Promise in Treating Frontal Fibrosing Alopecia, reveals research Dr Riya Dave27 April 2025 8:30 PM ISTAccording to a new study,Methotrexate microinfusion (MMP) is a well-tolerated and effective treatment for frontal fibrosing alopecia (FFA),...
